P2Y receptor subtypes evoke different Ca2+ signals in cultured aortic smooth muscle cells

Purinergic Signalling

Volumn 8, Issue 4, 2012, Pages 763-777

  Govindan, Sriram ^a,b   Taylor, Colin W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Novartis Institutes of Biomedical Research   (United Kingdom)

Author keywords

Aortic smooth muscle cells; Ca2+ signalling; Desensitisation; P2Y receptors

Indexed keywords

1 [[6 (3 METHOXYESTRA 1, 3, 5 (10) TRIEN 17BETA YL) AMINO] HEXYL] 1H PYRROLE 2, 5 DIONE; 1 [[6 (3 METHOXYESTRA 1, 3, 5 (10) TRIEN 17BETA YL) AMINO] HEXYL] 2, 5 PYRROLIDINEDIONE; 2 [2 [4 (4 NITROBENZYLOXY) PHENYL] ETHYL] ISOTHIOUREA METHANESULFONATE; CAFFEINE; CALCIUM ION; INOSITOL 1, 4, 5 TRISPHOSPHATE RECEPTOR; MRS 2365; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; NIMODIPINE; PHOSPHOLIPASE C; PURINERGIC P2 RECEPTOR AGONIST; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; RYANODINE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; AORTA; ARTICLE; CALCIUM CURRENT; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; NONHUMAN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS; SMOOTH MUSCLE FIBER;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; CALCIUM; CALCIUM SIGNALING; CELL LINE; CELLS, CULTURED; EVOKED POTENTIALS; INOSITOL 1,4,5-TRISPHOSPHATE; MYOCYTES, SMOOTH MUSCLE; RATS; RECEPTORS, PURINERGIC P2Y;

EID: 84867858995     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9323-6     Document Type: Article

References (47)

1. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M (2008) The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 456: 769-785.
2. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
3. 2+ handling in vascular smooth muscle cells is affected by proliferation. Pflugers Arch 20: 1225-1235.
4. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol 295: C779-C790.
5. Thyberg J (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169: 183-265.
6. Hao H, Gabbiani G, Bochaton-Piallat ML (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Artero Thromb Vasc Biol 23: 1510-1520.
7. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
8. Burnstock G (2002) Purinergic signaling and vascular cell proliferation and death. Artero Thromb Vasc Biol 22: 364-373.
9. 6-like receptor in arteries. Mol Pharmacol 62: 1438-1445.
10. 2+ signalling by P2Y receptors in cultured rat aortic smooth muscle cells. Br J Pharmacol 160: 1953-1962.
11. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
12. Erlinge D, Hou M, Webb TE, Barnard EA, Moller S (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248: 864-870.
13. 13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 311: 1038-1043.
14. 4 receptors. Biochem Pharmacol 71: 540-549.
15. 14 receptor. J Pharmacol Exp Ther 325: 588-594.
16. Brinson AE, Harden TK (2001) Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. Ser-333 and Ser-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor. J Biol Chem 276: 11939-11948.
17. 6 receptor. Eur J Pharmacol 329: 231-236.
18. 4 receptor. Mol Pharmacol 57: 926-931.
19. Brass D, Grably MR, Bronstein-Sitton N, Gohar O, Meir A (2011) Using antibodies against P2Y and P2X receptors in purinergic signaling research. Purinergic Signal 8: 61-79.
20. Lesh RE, Nixon GF, Fleischer S, Airey JA, Somlyo AP, Somlyo AV (1998) Localization of ryanodine receptors in smooth muscle. Circl Res 82: 175-185.
21. Thai TL, Churchill GC, Arendshorst WJ (2009) NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. Am J Physiol 297: F510-F516.
22. 2+ signalling: problems and pitfalls. Trends Pharmacol Sci 19: 370-375.
23. Santonastasi M, Wehrens XH (2007) Ryanodine receptors as pharmacological targets for heart disease. Acta Pharm Sinica 28: 937-944.
24. Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A, Rosen D, Thomas JM, Izumi M, Ganesan A, Galione A, Churchill GC (2009) Identification of a chemical probe for NAADP by virtual screening. Nat Chem Biol 5: 220-226.
25. 2+ signals. J Biol Chem 285: 38611-38616.
26. 3 receptors: toward understanding their activation. Cold Spring Harb Persp Biol 2: a004010.
27. Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL (2003) 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1, 4, 5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34: 97-108.
28. 2+ stores of permeabilized A7r5 cells. Cell Calcium 29: 111-116.
29. 2+ entry via STIM proteins. Cell Calcium 47: 1-10.
30. 2+ release. FASEB J 16: 1145-1150.
31. 2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352: 130-134.
32. + entry. Biochem Biophys Res Commun 357: 1177-1182.
33. 2+ exchange in cells expressing NCX1. J Biol Chem 271: 22391-22397.
34. CRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 23: 2425-2437.
35. 2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol 517: 121-134.
36. Putney JW (2009) Capacitative calcium entry: from concept to molecules. Immunol Rev 231: 10-22.
37. 3 receptors. J Physiol 536: 3-19.
38. Peinelt C, Lis A, Beck A, Fleig A, Penner R (2008) 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. J Physiol 586: 3061-3073.
39. Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, Potier M, Halligan KE, Alzawahra WF, Barroso M, Singer HA, Jourd'heuil D, Trebak M (2010) Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am J Physiol 298: C993-C1005.
40. 2+ pump in proliferating human arterial myocytes. Am J Physiol 297: C1103-C1112.
41. Lewis RS (2007) The molecular choreography of a store-operated calcium channel. Nature 446: 284-287.
42. Bolotina VM (2008) Orai, STIM1 and iPLA2β: a view from a different perspective. J Physiol 586: 3035-3042.
43. Zeng W, Yuan JP, Kim MS, Choi YJ, Huang GN, Worley PF, Muallem S (2008) STIM1 gates TRPC channels, but not Orai1, by electrostatic interaction. Mol Cell 32: 439-448.
44. Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L (2007) Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 104: 4682-4687.
45. Albert AP, Saleh SN, Peppiatt-Wildman CM, Large WA (2007) Multiple activation mechanisms of store-operated TRPC channels in smooth muscle cells. J Physiol 583: 25-36.
46. Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ (2005) P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105: 3552-3560.
47. Rodriguez-Rodriguez R, Yarova P, Winter P, Dora KA (2009) Desensitization of endothelial P2Y1 receptors by PKC-dependent mechanisms in pressurized rat small mesenteric arteries. Br J Pharmacol 158: 1609-1620.